Evidence map›Paper›PMID 27539094›Full record

ArticleScientific reports2016

Microbial Cryptotopes are Prominent Targets of B-cell Immunity.

Franz J J Rieder, Julia Biebl, Marie-Theres Kastner, Martina Schneider, Christof Jungbauer, Monika Redlberger-Fritz, William J Britt, Michael Kundi, Christoph Steininger

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Franz J J RiederDepartment of Medicine I, Div. of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Vienna, Austria.
Julia BieblDepartment of Medicine I, Div. of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Vienna, Austria.
Marie-Theres KastnerDepartment of Medicine I, Div. of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Vienna, Austria.
Martina SchneiderDepartment of Medicine I, Div. of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Vienna, Austria.
Christof JungbauerBlood Donation Center of the Austrian Red Cross for Vienna, Lower Austria and Burgenland, Vienna, Austria.
Monika Redlberger-FritzDepartment of Virology, Medical University of Vienna, Kinderspitalgasse 15, Vienna, Austria.
William J BrittDepartment of Pediatrics, Children's Hospital, Birmingham, USA.
Michael KundiInstitute for Environmental Hygiene, Medical University of Vienna, Vienna, Austria.
Christoph SteiningerDepartment of Medicine I, Div. of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Vienna, Austria.
Medical University of Vienna · ATAustrian Red Cross · ATChildren's of Alabama · US

Funding

ENVELOPE ASSEMBLY OF HUMAN CYTOMEGALOVIRUSR01AI035602 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BRITT, WILLIAM JARVIS · 1995 to 2018
$4.5M
Austrian Science Fund FWF P 25353Austrian Science Fund FWF P 28102NIAID NIH HHS R01 AI035602
6 · The paper itself

Abstract

B-cell recognition of microbial antigens may be limited by masking of epitopes within three-dimensional structures (cryptotopes). Here we report that unmasking of cryptotopes by unfolding whole cytomegalovirus (CMV) antigen preparations with the chaotropic reagent Urea and probing with immune sera from healthy individuals (n = 109) increased ELISA signals by 36% in comparison to folded CMV antigens (P < 0.001). ELISA signals increased also significantly upon unfolding of S. aureus or E. coli antigens, whereas unfolded influenza H1N1 or respiratory syncitial virus antigens yielded reduced or unchanged reactivity in comparison to folded ones, respectively. Blocking of CMV cryptotope-specific Abs by incubation of an immunoglobuline preparation and three sera with unfolded CMV antigens enhanced clearly the neutralizing capacity of this immunoglobuline preparation against CMV infection. Thus, B-cell immunity frequently targets cryptotopes on CMV but these Abs are non-neutralizing, may reduce the neutralizing effectiveness of pathogen-specific Abs, and increase during immune maturation following primary CMV infection. The observation of functional consequences of Abs specific for cryptotopes may open whole new avenues to a better understanding of the humoral immune response to CMV and development of more effective vaccines and immunoglobuline preparations.

Indexed as

AdultAgedAntibodies, BacterialAntibodies, ViralB-LymphocytesCytomegalovirusEpitopes, B-LymphocyteEscherichia coliHumansImmunity, CellularMaleMiddle AgedStaphylococcus aureusAntibodies, BacterialAntibodies, ViralEpitopes, B-Lymphocyte

Identifiers

PMID27539094
PMCPMC4990913
OpenAlexW2516458171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.